DC

Healthcare · Pharmaceuticals

Dishman Carbogen Amcis Ltd (DCAL)

₹115.57

Mkt cap
₹1,899 Cr
P/E ratio
—
P/B
0.27
Div yield
0.00%
ROE
1.58%
ROCE
3.14%
EPS (TTM)
—
Book value
₹426
52W range
115–274
Sector
Healthcare

Price history

Previous close

Dishman Carbogen Amcis Ltd is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries. [1]

NSE DCALBSE 540701
Health check
Cautious
ProfitabilityWeak
GrowthModerate
TechnicalsBearish
52-week range
−57.87% from high
₹116
₹115+0.50% from low₹274
Current
₹115.57
Prev close
₹118.53
Day
−2.50%
Price performance
1D
−2.22%
1W
−32.97%
1M
−17.23%
3M
−32.78%
6M
−45.30%
1Y
−53.49%
YTD
−54.64%

Financials

Revenue, profit & margin
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales587651655524789682716708653720851678507
YoY Sales growth-4%+2%+6%-28%+35%+5%+9%+35%-17%+5%+19%-4%-22%
Expenses526610592495642542564567504607688618461
Operating Profit614163291471401531411491131636046
OPM %10%6%10%6%19%21%21%20%23%16%19%9%9%
Other Income564-448-4228715164
Interest27333132374942434246433740
Depreciation75808571727279818484899190
Profit before tax-36-66-49-784227283931-1046-51-81
Tax %13%-10%42%0%21%83%-56%39%-114%24%53%13%-18%
Net Profit-41-60-70-78335432365-1322-58-67
EPS in Rs-2.61-3.80-4.46-4.952.110.302.751.494.16-0.831.39-3.69-4.26
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −13.63% · closed higher next day 0 of last 2
 Q1FY27Q2FY27
Broadcast14 Aug '26◦13 Nov '26◦
Earnings day−7.78%−19.48%
+1 day−11.29%−24.62%
+5 days−9.13%—
+15 days−10.03%—
+30 days−15.35%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
59.32%Promoter
Promoters59.32%
FIIs6.96%0.10
DIIs1.65%0.41
Public32.05%0.29
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,871.5036.494,49,0360.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,049.0085.832,93,3160.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,610.7080.781,75,3760.82%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,322.5093.661,25,4880.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,202.0026.461,19,9000.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,398.2041.711,16,7880.57%913−31.35%8,698−1.48%13.04%
Cipla₹1,417.0036.861,14,4780.92%852−35.05%7,404−2.44%15.49%
Dishman Carbogen₹121.15—1,8990.00%−67−202.24%507−22.26%3.14%
Median: 160 Co.₹439.3232.752,0010.08%13+33.73%179+21.23%14.94%

Filings